Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model.Karsten Ruscher, Andreas Meisel|PubMed|2002Cited by 452
Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from an<i>In Vitro</i>ModelKarsten Ruscher, Andreas Meisel|Journal of Neuroscience|2002Cited by 387
MicroRNA-124-loaded nanoparticles increase survival and neuronal differentiation of neural stem cells in vitro but do not contribute to stroke outcome in vivoCláudia Saraiva, Karsten Ruscher|PLoS ONE|2018Cited by 44
Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI)Jie Liu, YuHong Fu, Jianping Jia et al.|Neuroprotection/Neuroprotection (Chichester, England. Print)|2023Cited by 23
Plasticity-Enhancing Effects of Levodopa Treatment after StrokeDaniela Talhada, Karsten Ruscher|International Journal of Molecular Sciences|2021Cited by 12